138 related articles for article (PubMed ID: 2652512)
21. Elective cyclosporine conversion from triple therapy.
Chapman JR; Allen RD; Ekberg H; Lawrence S; Stewart JH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1631-2. PubMed ID: 2652532
[No Abstract] [Full Text] [Related]
22. Long-term outcome of cadaveric kidney grafts with triple drug therapy.
Amemiya H; Suzuki S; Hayashi R; Nakatani T
Transplant Proc; 1994 Aug; 26(4):2097-8. PubMed ID: 8066683
[No Abstract] [Full Text] [Related]
23. [Studies on the multiple-drug induction immunosuppressive therapies with cyclosporine after renal transplantation].
Imanishi M; Negita M; Ikegami M; Nishioka T; Ishii T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T
Nihon Hinyokika Gakkai Zasshi; 1991 Jun; 82(6):907-13. PubMed ID: 1881010
[TBL] [Abstract][Full Text] [Related]
24. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
[No Abstract] [Full Text] [Related]
25. Mizoribine as an alternative to azathioprine in triple-therapy immunosuppressant regimens in cadaveric renal transplantation.
Lee HA; Slapak M; Venkatraman G; Mason J; Digard N; Wise M
Transplant Proc; 1993 Aug; 25(4):2699-700. PubMed ID: 8356720
[No Abstract] [Full Text] [Related]
26. Cyclosporine: five years' experience in cadaveric renal transplantation.
Merion RM; White DJ; Thiru S; Evans DB; Calne RY
N Engl J Med; 1984 Jan; 310(3):148-54. PubMed ID: 6361559
[TBL] [Abstract][Full Text] [Related]
27. Recipient age--an important factor for the outcome of cadaver renal transplantation in patients treated with cyclosporine.
Lundgren G; Persson H; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Groth CG; Lindholm A; Weibull H
Transplant Proc; 1989 Feb; 21(1 Pt 2):1653-4. PubMed ID: 2652541
[No Abstract] [Full Text] [Related]
28. Effects of steroids in combination with other pharmacologic immunosuppressive agents.
Salaman JR
J Heart Transplant; 1986; 5(4):304-6. PubMed ID: 3305822
[TBL] [Abstract][Full Text] [Related]
29. A clinical study of renal transplant patients receiving triple-drug therapy--cyclosporine A, mizoribine, and prednisolone.
Marumo F; Okubo M; Yokota K; Uchida H; Kumano K; Endo T; Watanabe K; Kashiwagi N
Transplant Proc; 1988 Feb; 20(1 Suppl 1):406-9. PubMed ID: 3279630
[No Abstract] [Full Text] [Related]
30. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
[No Abstract] [Full Text] [Related]
31. Early fluctuation in cyclosporine A trough levels affects long-term outcome of kidney transplants.
Inoue S; Beck Y; Nagao T; Uchida H
Transplant Proc; 1994 Oct; 26(5):2571-3. PubMed ID: 7940795
[No Abstract] [Full Text] [Related]
32. A controlled trial of triple therapy in renal transplantation.
Salaman JR; Griffin PJ; Ross WB; Williams JD
Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
[No Abstract] [Full Text] [Related]
33. Comparison of three immunosuppressive regimens in high-risk patients: immunologic aspects.
Renna Molajoni E; Bachetoni A; Cinti P; Sallustio F; Rossi M; Pretagostini R; Orlandini A; Berloco P; Alfani D; Cortesini R
Transplant Proc; 1987 Feb; 19(1 Pt 3):1978-80. PubMed ID: 3079064
[No Abstract] [Full Text] [Related]
34. Kidney transplantation from elderly living donors.
Haberal M; Sert S; Altunkan S; Gülay H; Hamaloğlu E; Bulut O
Int J Artif Organs; 1991 Jun; 14(6):335-7. PubMed ID: 1885240
[TBL] [Abstract][Full Text] [Related]
35. Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function.
Tegzess AM; van Son WJ; de Maar EF; Beelen JM; Sluiter WJ; Huisman RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1635-7. PubMed ID: 2652534
[No Abstract] [Full Text] [Related]
36. Renal transplantation from living donors mismatched for two HLA haplotypes.
Sødal G; Albrechtsen D; Berg KJ; Bondevik H; Brekke IB; Fauchald P; Jakobsen A; Talseth T; Thorsby E; Flatmark A
Transplant Proc; 1987 Feb; 19(1 Pt 2):1509-10. PubMed ID: 3079022
[No Abstract] [Full Text] [Related]
37. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
Reissi D; Bardideh A; Samadzadeh B; Razi A
Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
[No Abstract] [Full Text] [Related]
38. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
39. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
Ebel H; Lange H
Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
[No Abstract] [Full Text] [Related]
40. Preliminary results of short-term combination immunosuppressions of mizoribine, azathioprine, and prednisolone with pretreatment to canine kidney transplantation.
Minami T; Watanabe T; Muto M; Wakao Y; Suzuki T; Takahashi M
J Vet Med Sci; 1993 Jun; 55(3):409-14. PubMed ID: 8357913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
